The beneficial effects of the activation of the SHH pathway in a porcine model of ischemia reperfusion opens a potentially interesting therapeutic prospective for patients suffering from a myocardial infarction to prevent the occurrence of reperfusion arrhythmias and reduce the infarct size. This evidence concerns the gene SHH and myocardial infarction.